🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Hong Liu

Nanjing University of Chinese Medicine

ORCID: 0000-0003-3685-6268

Also affiliated with Chinese Academy of Sciences, Shanghai Institute of Materia Medica, ZheJiang Academy of Agricultural Sciences, University of Chinese Academy of Sciences

ChemistryPharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

6in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 6 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 8 papers. Top paper: “An Alphavirus Replicon Particle Chimera Derived from Venezuelan Equine Encephalitis and Sindbis Viruses Is a Potent Gene-Based Vaccine Delivery Vector”.

An Alphavirus Replicon Particle Chimera Derived from Venezuelan Equine Encephalitis and Sindbis Viruses Is a Potent Gene-Based Vaccine Delivery Vector

Journal of Virology(2003)10.1128/jvi.77.19.10394-10403.2003

N/A

6.9DataRank · unranked

171 citations

Catherine E. Greer, Kent Thudium, Barbara Doe, Harold Legg, Hong Liu +8 more

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

The Lancet Respiratory Medicine(2020)10.1016/s2213-2600(20)30079-5

N/A

1.4DataRank · unranked

10679 citations

Yuan Yu, Jiqian Xu, Huaqing Shu, Jia'an Xia, Hong Liu +12 more

Discovery of spirohydantoins as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferases

Bioorganic & Medicinal Chemistry Letters(2021)10.1016/j.bmcl.2021.127854

N/A

0.806DataRank · unranked

22 citations

Richard F. Clark, Vikram Bhat, T. Matthew Hansen, Loren M. Lasko, Kenneth D. Bromberg +13 more

The Second-generation of Highly Potent Hepatitis C Virus (HCV) NS3/4A Protease Inhibitors: Evolutionary Design Based on Tailor-made Amino Acids, Synthesis and Major Features of Bio-activity

Current Pharmaceutical Design(2017)10.2174/1381612823666170522122424

N/A

0.791DataRank · unranked

29 citations

Yibing Wang, Jiang Wang, Tatsunori Sato, Kunisuke Izawa, Vadim A. Soloshonok +2 more

An approach to cyclic protocol validation

Computer Communications(1996)10.1016/s0140-3664(96)01152-8

N/A

0.410DataRank · unranked

4 citations

Raymond E. Miller, Hong Liu

Understanding interspecies drug response variations between human and rodent P2X7 receptors

Nature Communications(2025)10.1038/s41467-025-65847-0

N/A

0.345DataRank · unranked

9 citations

Danqi Sheng, Ji-Yuan Li, Tian-Tian Li, Jia-Bao Yao, Rui Zhang +14 more

UBC9-associated SUMOylation contributes to β-catenin activation and kidney fibrosis

Kidney International(2025)10.1016/j.kint.2025.07.005

N/A

0DataRank · unranked

4 citations

Jingzhen Wei, Yuqing Zeng, Min Yi, Yunqian Zhou, Kai Ai +11 more

LC–MS/MS Assay of Fluoropezil and Its Two Major Metabolites in Human Plasma: An Application to Pharmacokinetic Studies

Bioanalysis(2022)10.4155/bio-2022-0045

N/A

0DataRank · unranked

0 citations

Jiafeng Hu, Jiao Jing, Ying Liu, Jian Li, Yu Zhou +4 more